Hopp til innhold

Onkologi

Peroperativ behandling med autologt blod

Blodgjenvinning

Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: A systematic review and meta-analysis. (åpner nytt vindu)

Aijtink VJ, Rutten VC, Meijer B, de Jong R, Isaac J, Polak W, Perera M, Sneiders D, Hartog H

Kilde‎: Ann Surg. 2022;276(2):239-45. 

Arkiv‎: PubMed 36036990

DOI‎: 10.1097/SLA.0000000000005476

https://pubmed.ncbi.nlm.nih.gov/36036990/ (åpner nytt vindu)

Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. (åpner nytt vindu)

Akbulut S, Kayaalp C, Yilmaz M, Ince V, Ozgor D, Karabulut K, Eris C, Toprak HI, Aydin C, Yilmaz S.

Kilde‎: World J Gastroenterol 2013;19(10):1625-31.

Arkiv‎: PubMed 23538988

DOI‎: 10.3748/wjg.v19.i10.1625

https://www.ncbi.nlm.nih.gov/pubmed/23538988 (åpner nytt vindu)

Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? (åpner nytt vindu)

Araujo RL, Pantanali CA, Haddad L, Rocha Filho JA, D'Albuquerque LA, Andraus W.

Kilde‎: World J Gastrointest Surg 2016;8(2):161-8.

Arkiv‎: PubMed 26981190

DOI‎: 10.4240/wjgs.v8.i2.161

https://www.ncbi.nlm.nih.gov/pubmed/26981190 (åpner nytt vindu)

Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. (åpner nytt vindu)

Bower MR, Ellis SF, Scoggins CR, McMasters KM, Martin RC.

Kilde‎: Ann Surg Oncol 2011;18(1):166-73.

Arkiv‎: PubMed 21222043

DOI‎: 10.1245/s10434-010-1228-4

https://www.ncbi.nlm.nih.gov/pubmed/21222043 (åpner nytt vindu)

Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. (åpner nytt vindu)

Gorin MA, Eldefrawy A, Manoharan M, Soloway MS.

Kilde‎: World J Urol 2012;30(3):379-83.

Arkiv‎: PubMed 21847657

DOI‎: 10.1007/s00345-011-0746-4

https://www.ncbi.nlm.nih.gov/pubmed/21847657 (åpner nytt vindu)

Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. (åpner nytt vindu)

Han S, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, Lee SK, Gwak MS.

Kilde‎: Ann Surg 2016;264(2):339-43.

Arkiv‎: PubMed 26501715

DOI‎: 10.1097/SLA.0000000000001486

https://www.ncbi.nlm.nih.gov/pubmed/26501715 (åpner nytt vindu)

Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. (åpner nytt vindu)

Kumar N, Chen Y, Zaw AS, Nayak D, Ahmed Q, Soong R, Wong HK.

Kilde‎: Lancet Oncol 2014;15(1):e33-41.

Arkiv‎: PubMed 24384492

DOI‎: 10.1016/S1470-2045(13)70245-6

https://www.ncbi.nlm.nih.gov/pubmed/24384492 (åpner nytt vindu)

Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? (åpner nytt vindu)

Kumar N, Zaw AS, Kantharajanna SB, Khoo BL, Lim CT, Thiery JP

Kilde‎: Transfus Med 2017;27 Suppl 5:327-34.

Arkiv‎: PubMed 28833768

DOI‎: 10.1111/tme.12453

https://www.ncbi.nlm.nih.gov/pubmed/28833768 (åpner nytt vindu)

The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. (åpner nytt vindu)

Mirhashemi R, Averette HE, Deepika K, Estape R, Angioli R, Martin J, Rodriguez M, Penalver MA.

Kilde‎: Am J Obstet Gynecol 1999;181(6):1310-5.

Arkiv‎: PubMed 10601905

https://www.ncbi.nlm.nih.gov/pubmed/10601905 (åpner nytt vindu)

Intraoperative cell salvage during radical cystectomy does not affect long-term survival. (åpner nytt vindu)

Nieder AM, Manoharan M, Yang Y, Soloway MS.

Kilde‎: Urology 2007;69(5):881-4.

Arkiv‎: PubMed 17482926

DOI‎: 10.1016/j.urology.2007.01.060

https://www.ncbi.nlm.nih.gov/pubmed/17482926 (åpner nytt vindu)

Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. (åpner nytt vindu)

Raval JS, Nelson JB, Woldemichael E, Triulzi DJ.

Kilde‎: Transfusion 2012;52(12):2590-3.

Arkiv‎: PubMed 22612661

DOI‎: 10.1111/j.1537-2995.2012.03682.x

https://www.ncbi.nlm.nih.gov/pubmed/22612661 (åpner nytt vindu)

Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy? (åpner nytt vindu)

Trudeau JD, Waters T, Chipperfield K.

Kilde‎: Can J Anaesth 2012;59(11):1058-70.

Arkiv‎: PubMed 22996966

DOI‎: 10.1007/s12630-012-9781-x

https://www.ncbi.nlm.nih.gov/pubmed/22996966 (åpner nytt vindu)

Blood salvage and cancer surgery: a meta-analysis of available studies. (åpner nytt vindu)

Waters JH, Yazer M, Chen YF, Kloke J.

Kilde‎: Transfusion 2012;52(10):2167-73.

Arkiv‎: PubMed 22321196

DOI‎: 10.1111/j.1537-2995.2011.03555.x

https://www.ncbi.nlm.nih.gov/pubmed/22321196 (åpner nytt vindu)

Akutt normovolemisk hemodilusjon

Cerebral effect of acute normovolemic hemodilution during brain tumor resection. (åpner nytt vindu)

Daif AA, Hassan YM, Ghareeb NA, Othman MM, Mohamed SA.

Kilde‎: J Neurosurg Anesthesiol 2012;24(1):19-24.

Arkiv‎: PubMed 21904221

DOI‎: 10.1097/ANA.0b013e31822f0346

https://www.ncbi.nlm.nih.gov/pubmed/21904221 (åpner nytt vindu)

Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. (åpner nytt vindu)

Habler O, Schwenzer K, Zimmer K, Prager M, König U, Oppenrieder K, Pape A, Steinkraus E, Reither A, Buchrot A, Zwissler B.

Kilde‎: Int J Oral Maxillofac Surg 2004;33(5):467-75.

Arkiv‎: PubMed 15183411

DOI‎: 10.1016/j.ijom.2003.10.007

https://www.ncbi.nlm.nih.gov/pubmed/15183411 (åpner nytt vindu)

A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. (åpner nytt vindu)

Jarnagin WR, Gonen M, Maithel SK, Fong Y, D'Angelica MI, Dematteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M.

Kilde‎: Ann Surg 2008;248(3):360-9.

Arkiv‎: PubMed 18791356

DOI‎: 10.1097/SLA.0b013e318184db08

https://www.ncbi.nlm.nih.gov/pubmed/18791356 (åpner nytt vindu)